BioXcel Therapeutics (BTAI)

Quick facts

Marketed products

• Precedex · Neuroscience
  Precedex works by activating alpha-2 adrenergic receptors in the brain, which reduces the activity of neurons and produces sedative effects.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• BioXcel Therapeutics portfolio CI brief
• BioXcel Therapeutics pipeline updates RSS